BioNTech SE Cost Of Sales
BioNTech SE (BNTX) reported Cost Of Sales of EUR 641.80 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Cost of Sales
ifrs-full:CostOfSales · last filed 2026-03-10
| Period end | Cost Of Sales 12 month | Cost Of Sales 12 month as first filed |
|---|---|---|
| 2025-12-31 | 641.80M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 541.30M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 599.80M EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 3.00B EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | 2.91B EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | 59.30M EUR 20-F · filed 2023-03-27 | 59.33M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 17.40M EUR 20-F/A · filed 2022-10-26 | 17.36M EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | 13.69M EUR 20-F · filed 2021-03-30 | |
| 2017-12-31 | 9.32M EUR 20-F · filed 2020-03-31 |